Oramed Pharmaceuticals Stock Price

0.04 (0.39%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.39% 10.30 00:00:09
Open Price Low Price High Price Close Price Prev Close
10.8733 10.04 10.8733 10.30 10.26
Bid Price Ask Price Spread News
10.32 15.75 5.43 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,964 248,952 $ 10.34 $ 2,573,542 426,725 2.40 - 12.70
Last Trade Time Type Quantity Stock Price Currency
18:42:04 30 $ 10.30 USD

Oramed Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 311.35M 30.23M 27.28M $ 2.71M $ - -0.58 -12.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -453.13k 58.60%

more financials information »

Oramed Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ORMP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.638811.7910.0410.75522,372-0.3388-3.18%
1 Month8.8011.798.2010.27462,8471.5017.05%
3 Months10.5612.706.989.95667,687-0.26-2.46%
6 Months2.6412.702.4657.73779,2437.66290.15%
1 Year3.2012.702.407.04448,9357.10221.88%
3 Years6.9312.701.846.31202,8893.3748.63%
5 Years7.9112.701.846.56141,7852.3930.21%

Oramed Pharmaceuticals Description

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Your Recent History
Oramed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.